Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Desmond A O'Farrell, M.Sc.

Concepts (135)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brachytherapy26202312241.610 Why?
Radiotherapy Planning, Computer-Assisted13202316790.580 Why?
Radiotherapy Dosage22202329200.420 Why?
Uterine Cervical Neoplasms5202120440.280 Why?
Genital Neoplasms, Female220235380.220 Why?
Carcinoma, Merkel Cell320133290.210 Why?
Rectum520179000.200 Why?
Penile Neoplasms120201580.150 Why?
Radiation Injuries3201312030.140 Why?
Carcinoma, Adenosquamous12016670.130 Why?
Iodine Radioisotopes3200910340.130 Why?
Colon, Sigmoid320171240.130 Why?
Organs at Risk220173680.130 Why?
Neoplasm Recurrence, Local8201694420.120 Why?
Software Validation12014590.120 Why?
Catheters320234270.110 Why?
Radiotherapy, Computer-Assisted22010900.100 Why?
Cystadenocarcinoma, Papillary12012560.100 Why?
Radiometry420148170.100 Why?
Catheters, Indwelling120144360.090 Why?
Skin Diseases1202010850.090 Why?
Adenocarcinoma, Clear Cell120122180.090 Why?
Chordoma319993490.090 Why?
Prostatic Neoplasms42014112290.090 Why?
Skull Base Neoplasms319992810.090 Why?
Endometrial Neoplasms2201213860.090 Why?
Urinary Bladder3201711620.080 Why?
Carcinoid Tumor220092240.080 Why?
Radiation Protection120124280.080 Why?
Skin Neoplasms3201358640.070 Why?
Imaging, Three-Dimensional2201340770.070 Why?
Salvage Therapy1201412770.070 Why?
Thoracic Neoplasms120092690.070 Why?
Polyethylene Glycols1201211970.070 Why?
Vaginal Neoplasms120061050.060 Why?
Stereotaxic Techniques120085590.060 Why?
Radiotherapy2200815060.060 Why?
Neoplasm Metastasis2201349260.060 Why?
Sarcoma2201318060.060 Why?
Uterine Neoplasms1201214240.060 Why?
Mediastinal Neoplasms120064030.060 Why?
Consensus1201332140.050 Why?
Magnetic Resonance Imaging52023368610.050 Why?
Treatment Outcome122020654850.050 Why?
Dose-Response Relationship, Radiation320138770.050 Why?
Ultrasonography1201460010.050 Why?
Carcinoma, Squamous Cell1201640640.050 Why?
Aged, 80 and over112020597380.040 Why?
Societies, Medical1201339670.040 Why?
Radiotherapy, Adjuvant3201317930.040 Why?
Adenocarcinoma1201664010.040 Why?
Aged1720201717900.040 Why?
Cicatrix120057990.040 Why?
Breast Neoplasms32013211870.040 Why?
Photons219995950.040 Why?
Humans3120237688870.040 Why?
Automation120205890.040 Why?
Radiation Dosage2201719700.030 Why?
Tomography, X-Ray Computed62020207760.030 Why?
Middle Aged1520202237400.030 Why?
Practice Guidelines as Topic1201374600.030 Why?
Chondrosarcoma119983060.030 Why?
Vagina220128480.030 Why?
SEER Program1202014730.030 Why?
Female1820233974640.030 Why?
Mammaplasty1200512630.030 Why?
Mammography1200524340.030 Why?
Protons1199811130.030 Why?
Brain Stem119978620.030 Why?
Liver Neoplasms1200843630.030 Why?
Retrospective Studies72017818920.020 Why?
Follow-Up Studies42014393940.020 Why?
Tumor Burden1201619130.020 Why?
Temporal Lobe1199817280.020 Why?
Watchful Waiting120144980.020 Why?
Disease-Free Survival2201668560.020 Why?
Adult1120172238180.020 Why?
Feasibility Studies2201453230.020 Why?
Male1320203652490.020 Why?
Analysis of Variance2201362420.020 Why?
Survival Rate22013128730.020 Why?
Mastectomy2200818500.020 Why?
Mastectomy, Segmental120139600.020 Why?
Neoplasm Staging22013112620.020 Why?
Mediastinum120092720.020 Why?
Time Factors32016402660.020 Why?
Particle Accelerators120081730.020 Why?
Technology, Radiologic120071600.020 Why?
Hydrogels120127450.020 Why?
Prostate1201417810.020 Why?
Prospective Studies52013549500.020 Why?
Urethra120084070.020 Why?
Kaplan-Meier Estimate1201665460.020 Why?
Ultrasonography, Interventional1201415240.020 Why?
Remission Induction1201124110.020 Why?
Leg1201010890.020 Why?
Leiomyosarcoma120094250.020 Why?
Neoplasm Invasiveness1201336290.020 Why?
Skin Transplantation1201010970.010 Why?
Combined Modality Therapy2201185590.010 Why?
Neoplasm, Residual1200910190.010 Why?
Pelvis120087380.010 Why?
Reproducibility of Results22014202440.010 Why?
Linear Models1201358900.010 Why?
Therapy, Computer-Assisted120052650.010 Why?
Equipment Design1201035290.010 Why?
Survival Analysis12014101150.010 Why?
Carcinoma, Ductal, Breast1200810930.010 Why?
Massachusetts1201388880.010 Why?
Breast1200819760.010 Why?
Phantoms, Imaging1200825330.010 Why?
Neoplasms12008223900.010 Why?
Adolescent42016892470.010 Why?
Chemotherapy, Adjuvant1200635540.010 Why?
Palliative Care1201336440.010 Why?
Lymph Nodes1200834730.010 Why?
Young Adult22016601100.010 Why?
Prevalence12013158750.010 Why?
Antineoplastic Combined Chemotherapy Protocols12016118860.010 Why?
Heart1200844480.010 Why?
Pilot Projects1200687420.010 Why?
Quality of Life12014135100.010 Why?
Prognosis12013300440.010 Why?
Clinical Trials as Topic1200880550.010 Why?
Risk Assessment12013243300.010 Why?
Carcinoma, Non-Small-Cell Lung1200954340.010 Why?
Cohort Studies12013418000.010 Why?
Lung12008100970.010 Why?
Algorithms12007141990.000 Why?
Sex Factors11999106410.000 Why?
Proportional Hazards Models11999125630.000 Why?
United States12013731800.000 Why?
Lung Neoplasms12009135930.000 Why?
Multivariate Analysis11997120930.000 Why?
Child21998809690.000 Why?
O'Farrell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (135)
Explore
_
Co-Authors (42)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.